| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
13,640,000 |
| Market
Cap: |
10.78(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.79 - $0.79 |
|
| Level
I Sector: |
Industrials |
| Level
II Sector: |
Diversified Services |
| Level
III Sector: |
Business Services |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Sonnet BioTherapeutics Holdings is a clinical-stage biopharmaceutical company with a proprietary technology for developing biologic medicines it refers to as FHAB (Fully Human Albumin Binding). Co. has a pipeline of therapeutic compounds focused primarily on oncology indications of unmet medical need, including SON-080, a low-dose formulation of Interleukin 6 which is in development for Chemotherapy Induced Peripheral Neuropathy; SON-1010, which is being developed for solid tumor indications, including non-small cell lung cancer and head and neck cancer, as well as for antiviral applications; and SON-1210, which is being developed for solid tumor indications, including colorectal cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
479,855 |
539,855 |
| Total Buy Value |
$0 |
$0 |
$106,550 |
$141,650 |
| Total People Bought |
0 |
0 |
5 |
5 |
| Total Buy Transactions |
0 |
0 |
6 |
7 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Cross John Harry Iii |
Chief Financial Officer |
• – – |
2020-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
78,214 |
78,214 |
|
- |
|
| Dexter Susan |
Chief Technical Officer |
• – – |
2020-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
73,613 |
73,613 |
|
- |
|
| Mohan Pankaj |
Chairman, President and CEO |
• • – |
2020-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
319,866 |
322,266 |
|
- |
|
| Dyrness Albert D. |
Director |
– • – |
2020-06-11 |
4 |
B |
$4.01 |
$9,660 |
D/D |
2,409 |
4,966 |
2.39 |
- |
|
| Mohan Pankaj |
Chairman, President and CEO |
• • • |
2020-06-10 |
4 |
B |
$4.09 |
$9,816 |
D/D |
2,400 |
2,400 |
3.15 |
- |
|
| Mohan Pankaj |
Chairman, President and CEO |
• • • |
2020-04-01 |
4/A |
A |
$0.00 |
$0 |
I/I |
930,705 |
930,705 |
|
- |
|
| Cini John K. |
Chief Scientific Officer |
• – – |
2020-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
159,857 |
159,857 |
|
- |
|
| Dyrness Albert D. |
Director |
– • – |
2020-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,557 |
2,557 |
|
- |
|
| Rao Raghu |
Director |
– • – |
2020-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
213 |
213 |
|
- |
|
| Bhatt Nailesh |
Director |
– • – |
2020-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,328 |
5,328 |
|
- |
|
| Mohan Pankaj |
Chairman, President and CEO |
• • – |
2020-04-01 |
4 |
A |
$0.00 |
$0 |
I/I |
1,599,108 |
1,591,116 |
|
- |
|
| Griffith Donald J. |
Director |
– • – |
2020-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
79,928 |
79,928 |
|
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2020-03-23 |
4 |
B |
$0.54 |
$4,078 |
I/I |
7,000 |
35,462 |
2.58 |
61% |
|
| Glick Frederick L |
President |
• – – |
2020-03-23 |
4 |
B |
$0.51 |
$2,528 |
D/D |
5,000 |
4,000 |
2.66 |
61% |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2020-01-31 |
4 |
B |
$0.00 |
$0 |
I/I |
206 |
10,223 |
2.58 |
23% |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2019-12-10 |
4 |
B |
$0.62 |
$124 |
I/I |
200 |
5,223 |
2.58 |
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2019-11-19 |
4 |
B |
$0.69 |
$1,410 |
I/I |
2,000 |
32,462 |
2.58 |
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2019-11-19 |
4 |
OE |
$0.05 |
$50 |
I/I |
1,000 |
33,462 |
|
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2019-11-17 |
4 |
B |
$0.64 |
$106 |
I/I |
165 |
4,858 |
2.58 |
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2019-08-23 |
4 |
B |
$0.57 |
$572 |
I/I |
1,000 |
4,358 |
2.58 |
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2019-08-19 |
4 |
B |
$0.61 |
$3,050 |
I/I |
5,000 |
30,962 |
2.58 |
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2019-07-30 |
4 |
B |
$1.12 |
$118 |
I/I |
105 |
3,358 |
2.58 |
- |
|
| Pruitt Michael |
CEO, Chairman |
• • – |
2019-06-27 |
4 |
OE |
$1.00 |
$500 |
I/I |
500 |
25,962 |
|
- |
|
| Glick Frederick L |
President |
• – – |
2019-06-27 |
4 |
B |
$1.17 |
$4,680 |
I/I |
4,000 |
4,000 |
1.91 |
- |
|
| Wagoner J Eric |
Director |
– • – |
2019-06-24 |
4 |
OE |
$1.00 |
$5,000 |
D/D |
5,000 |
19,561 |
|
- |
|
168 Records found
|
|
Page 3 of 7 |
|
|
